Sort
82,697 grants matching “vaccine development”
An Advanced Vaccine Candidate To Prevent Zika Virus Infection
$1,341,359Mark K Slifka · Oregon Health & Science University · R01 · FY2018 · AI
Development of stable and rapidly acting adjuvanted vaccines for biodefense
$1,341,348Robert Newton Brey · Soligenix, Inc. · U01 · FY2012 · AI
Malaria Drug Resistance and Disease Virulence
$1,341,326Thomas E Wellems · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Closing Research Gaps in Antiretroviral Treatment for Pregnant Women and Infants Living with HIV
$1,340,804Roger L Shapiro · Harvard School Of Public Health · P01 · FY2021 · HD
Host Genetics Core
$1,340,803Norman L Letvin · Duke University · U19 · FY2011 · AI
CTL and HIV Polymorphisms in Heterosexual Transmission
$1,340,695Eric Hunter · Emory University · R01 · FY2013 · AI
Development of Recombinant Toxins to Treat Hematologic Malignancies
$1,340,622Robert Kreitman · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Pathogenesis and countermeasures of poxviruses, hemorrhagic fever viruses, MERS
$1,340,561Peter Jahrling · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Environmental/genetic Risk Factors and Pathogenesis of Autoimmune Disease
$1,340,432Fred William Miller · Environmental Health Sciences · Z01 · FY2007 · ES
Studies on Arthropod Vectors of Disease
$1,340,377Robert Gwadz · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
EPITOPE BASED DNA VACCINES FOR AIDS THERAPY
$1,339,852Idm Pharma, Inc. · P01 · FY2003 · AI
Influenza Viral Pathogenesis
$1,339,791Jeffery Taubenberger · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Miami Womens Interagency HIV Study WIHS
$1,339,739Margaret A Fischl · University Of Miami School Of Medicine · U01 · FY2016 · AI
Glycolipid Presentation by CD1d
$1,339,665Albert S. Bendelac · University Of Chicago · P01 · FY2010 · AI
Characterization and improvement of graft versus leukemia effects
$1,339,575Austin J Barrett · National Heart, Lung, And Blood Institute · ZIA · FY2013 · HL
Immunobiology and immunotherapy of leukemia
$1,339,575Austin J Barrett · National Heart, Lung, And Blood Institute · ZIA · FY2013 · HL
Universal room temperature stable influenza nanovaccine
$1,339,376Balaji Narasimhan · Iowa State University · R01 · FY2019 · AI
Therapeutic Vaccination for HIV Using VEE Vectors
$1,338,827University Of North Carolina Chapel Hill · P01 · FY2003 · AI
EPITOPE BASED DNA VACCINES FOR AIDS THERAPY
$1,338,746Idm Pharma, Inc. · P01 · FY2001 · AI
Pandemic Influenza Translational Research and novel universal countermeasure development
$1,338,694Matthew Memoli · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Pediatric AIDS Clinical Trials Unit
$1,338,613Children'S Memorial Hospital (Chicago) · U01 · FY2003 · AI
HUMAN MELANOMA--ETIOLOGY, PROGRESSION AND THERAPY
$1,338,407Wistar Institute · P01 · FY2002 · CA
Immunotherapy to prevent drug-resistant tuberculosis
$1,337,935Rhea N Coler · Access To Advanced Health Institute · R01 · FY2018 · AI
ESTABLISHMENT OF SPECIFIC PATHOGEN FREE RHESUS AND PIGTA
$1,337,758Oregon Health And Science University · U24 · FY2005 · RR
Non-Human Primate Core (NHP Core)
$1,337,754Koen K Van Rompay · Duke University · P01 · FY2018 · AI